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Abstract--Human neutrophils (PMNs) which have been incubated with lipoteichoic 
acid (LTA) from group A streptococci generated large amounts of superoxide (O~- 
chemiluminescence and hydrogen peroxide when challenged with anti-LTA antibod- 
ies. Cytochalasin B further enhanced Oy generation. The onset of O2 generation by 
the LTA-anti-LTA complexes was much faster than that induced by BSA-anti-BSA 
complexes. LTA-treated PMNs generated much less 02 when challenged with BSA 
complexes, suggesting that LTA might have blocked, nonspecifically, some of the 
Fe receptors on PMNs. PMNs treated with LTA-anti-LTA complexes further inter- 
acted with bystander nonsensitized PMNs resulting in enhanced O~-generation, sug- 
gesting that small numbers of LTA-sensitized PMNs might recruit additional PMNs 
to participate in the generation of toxic oxygen species. Protelolytic enzyme treat- 
ment of PMNs further enhanced the generation of 02 by PMNs treated with LTA- 
anti-LTA. Superoxide generation could also be induced when PMNs and anti-LTA 
antibodies interacted with target cells (fibroblasts, epithelial cells) pretreated with 
LTA. This effect was also further enhanced by pretreatment of the target cells with 
proteases. PMNs incubated with LTA released lysosomal enzymes following treat- 
ment with anti-LTA antibodies. The amounts of phosphatase, /3-glucoronidase, N- 
acetylglucosaminidase, mannosidase, and lysozyme release by LTA-anti-LTA com- 
plexes were much smaller than those released by antibody or histone-opsonized 
streptococci, suggesting that opsonized particles are more efficient lysosomal enzyme 
releasers. However, since the amounts of O~- generated by the LTA complexes 
equaled those generated by the opsonized particles, it is assumed that the signals for 
triggering a respiratory burst and lysosomal enzyme secretion might be different. 
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Generation of 0 2 by LTA complexes was strongly inhibited by lipoxygenase inhib- 
itors but not by cyclooxigenase inhibitors. Also phenylbutazone, trifluorperazine, 
and DASA markedly inhibited 02  generation induced by LTA complexes. These 
data suggest that bacterial products in the presence of antibody might have important 
biological effects on phagocytic ceils and that these effects may be inimical to the 
host. 
INTRODUCTION 
Lipoteichoic acid (LTA) is an ampiphatic macromolecular substance that is 
associated with the cell wall and protoplast membrane of Gram-positive bacteria 
(1-3). LTA is composed of polyglycerophosphate or polyribitol phosphate 
linked to alanine and to a fatty acid (2). LTA was previously identified as the 
cell-sensitizing agent present in culture supernates of many Gram-positive 
microorganisms (4). 
While the bulk of LTA is firmly bound the bacterial cells (3), some LTA 
is always present in culture supernates (4-9). LTA can be released in large 
quantities following treatment of washed bacteria either with phenol (7-9) or 
with cationic agents (10). Substantial amounts of LTA can also be released 
during growth of bacteria in the presence of penicillin (11) or with penicillin 
and fibronectin (12). LTA derived from all Gram-positive bacteria cross-react 
immunologically (13). One of the most important characteristics of LTA is its 
capacity to bind spontaneously, via its lipid moiety, to membranes of mam- 
malian cells (4-9, 14-18). LTA has also been shown to mediate the adherence 
of bacteria to epithelial surfaces, thus facilitating their penetration into tissues 
(15). The adherence of LTA to red blood cells is markedly enhanced by a vari- 
ety of proteases (19) and both phospholipids and cholesterol of red blood cell 
membranes might function as binding sites for LTA (19). 
Red blood cells that had been presensitized with LTA undergo very strong 
agglutination (4-9, 19-21) and lysis (19, 20-23) following treatment with anti- 
LTA antibodies plus serum complement (complement-dependent cellular cyto- 
toxicity or passive immune kill). Antibodies to LTA are found in the IgM and 
IgG fraction of serum (20). LTA, even in high concentrations, is nontoxic if 
added to cells in the presence of serum (19, 20) but toxicity to target cells has 
been reported when it was employed in serum-free media (24-26). 
LTA is a potent activator of complement (19, 20) via both the classical 
(26) and alternative pathways (27). It releases lysosomal enzymes from mac- 
rophages (28), inhibits chemotaxis of neutrophils (29) and phagocytosis (30), 
modulates the mitogenicity of lymphocytes (31, 32) and the immune responses 
(33), and induces bone resorption (35, 36), arthritis (20), encephalitis (36), and 
nephropathy (37). LTA also induces antibody-dependent cellular cytotoxicity 
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(38), the generation of tumor necrosis factor (39), and inhibition of collagen 
synthesis by fibroblasts (40). 
LTA is also considered to function as the natural regulator of the autolytic 
wall enzymes of certain Gram-positive bacteria (41-43). Removal of LTA from 
Gram-positive bacterial by penicillin is thought to mediate the bactericidal effect 
of t3-1actam antibiotics leading to bacteriolysis (44, 45). 
Since LTA readily binds to neutrophils and further interacts with anti-LTA 
antibodies, and since immune complexes are known to activate leukocytes to 
generate oxygen radicals (46), we studied the role of LTA-anti-LTA com- 
plexes, bound to neutrophils, in the generation of superoxide and chemilumi- 
nescence, and their role in the release of lysosomal enzymes. 
MATERIALS AND METHODS 
Lipoteichoic Acid (LTA). LTA was isolated from group A streptococci (type 3 strain C203S) 
as described (8). It was further purified according to Fischer et al. (47). We are indebted to Makor 
Chemicals (Sigma, Israel) for the generous gift of LTA. Lyophilized LTA was dissolved in normal 
saline and kept at - 2 0 ~  
Determination of LTA. LTA was assayed quantitatively by a modified passive hemagglu- 
tination test (PHG) employing a standard preparation of rabbit anti-LTA immunoglobulin kindly 
supplied by Makor Chemicals. Human red blood cells (RBC) obtained from healthy blood donors 
were washed several times in saline. A 1% RBC suspension in PBS (saline-buffered with 0.05 M 
phosphate, pH 7.4) was treated for 20 min at 37~ with various concentrations of LTA in the 
absence or presence of papain (20/xg/ml) (Sigma Chemical Co., St. Louis, Missouri) and L-cys- 
teine (10 /zg/ml) (19, 21). The treated cells were washed in PBS and resuspended in the same 
volume of PBS. Twofold dilutions of a standard anti-LTA globulin were prepared in a final volume 
of 0.2 ml PBS employing disposable polyethylene tubes; 50 /d  of LTA-sensitized RCS were then 
added and the tubes shaken at 37~ for 20 min. The titer of PHG was determined after centrifu- 
gation at 2000 rpm for 15 sec in a Clay-Adams serofuge. The titer of PHG was determined as the 
highest dilution of anti-LTA which still induced passive hemagglutination as described (19, 20). 
Results were expressed as hemagglutination units per milligram of immunoglobulin anti-LTA. The 
anti-LTA preparation used contained approximately 39,000 units/mg protein. 
In a modified PHG assay both the sensitization of RBC by LTA and the dilutions of anti- 
LTA globulin were performed in a slightly hypotonic PBS (0.6% NaC1) (I. Ginsburg and S. 
Portnoy, unpublished results). Under these conditions much smaller amounts of LTA could be 
detected by PHG. This approach was taken since it was previously shown (48) that lysis of  RBC 
by streptolysin S of a group A streptococci was considerably enhanced by slightly hypotonic buff- 
ers. Hypotonicity might stretch the RBC membrane and expose more binding sites for LTA. 
Human Neutrophils (PMNs). Human neutrophils were obtained by consent from healthy 
blood donors. PMNs were obtained by centrifugation of heparinized blood in a Ficoll-Hypaque 
gradient followed by dextran sedimentation (49). Residual RBC were tysed by hypotonic saline. 
The PMNs were resuspended in Hanks'  balanced salt solution (HBSS) buffered with 1 mM HEPES 
buffer, pH 7.4 (49). In some cases, we suspended the PMNs in HBSS-HEPES containing 10 mM 
sodium azide. 
Target Cells. Mouse skin fibroblasts (strain LTK) and green monkey kidney epithelial cells 
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(GBM) provided by the Department of  Virology, Medical School, Hebrew University. The cells 
were cultivated in 50-ml Falcon flasks in RPMI 1640 medium containing 10 % fetal bovine serum. 
Confluent monolayers were trypsinized, washed in HBSS, resuspended in HBSS, and treated for 
15-20 min with LTA (see below). 
Generation of Superoxide (02). PMNs (1-5 • 106/ml) were first sensitized for 20 min at 
37~ with LTA (1-150 /~g/ml). The cells were washed in HBSS to remove unbound LTA and 
further treated for 15 min at 37~ with rabbit anti-LTA globulin (10-250/zg protein/ml) in the 
presence of 80 #M cytochrome c (type III, Sigma) PMNs were also stimulated with an immune 
complex prepared by mixing 100/xl of a rabbit anti-BSA globulin (975 ~tg Nitrogen/ml) in 1 ml 
saline, with 120 #g of BSA. The complexes were washed in saline and resuspended in 1 ml saline; 
10-15 tzl of the preformed complex was used to stimulate PMNs in the presence of cytochrome c. 
In some experiments cytochalasin B (CYB) (2.5/~g/ml, Sigma) was added to the reaction mixtures. 
The LTA-anti-LTA and the immune complex-treated ceils were shaken for 15 min at 37~ in a 
water bath. The tubes were then centrifuged for 10 min at 150g, and the superoxide dismutase 
(SOD) -inhibitable reduction of cytochrome c was read in a double-beam Unicam SP 1700 spec- 
trophotometer at 550 nm (49). The amounts of superoxide generated were calculated as described 
(49, 50). 
Determination of Hydrogen Peroxide (11202). H202 was determined by the method of Thur- 
man et al. (51). Briefly, to stimulated PMNs in HBSS + azide, 200/~1 of TCA (30%) were added. 
The tubes were centrifuged at 2000 rpm for 5 min. The supernates were transferred to fresh poly- 
ethylene tubes and 200 #1 of Fe(NH4)SO 4 - 12 H20 (19 mg/5 ml distilled water) were added, 
followed by 100 #1 of a 25% solution of NaCNS. The tubes were vortexed and incubated at room 
temperature for 5 min to allow maximal development of  the color which was read at 480 nm. A 
standard H202 assay was run daily. The results were expressed as nanomoles per number of  PMNs 
per 10 min. 
Measurement of Chemiluminescence (CL). Luminol-dependent CL was induced in PMNs 
by LTA-ant i-LTA complexes, as described for polycation-opsonized bacteria (52). Briefly, PMNs 
(1-5 • 106) were pretreated for 15 min at 37~ with various concentrations of LTA. The cells 
were washed in HBSS-HEPES and various amounts of anti-LTA globulin were added. The tubes 
were vortexed and immediately transferred to an LKB-Wallac 1250 luminometer which had been 
equilibrated at 37~ by water circulation. CL was monitored on a recorder, as millivolts (49). 
Release of Lysosomal Enzymes by Stimulated PMNs. Human PMNs (5 x 106/ml) were 
treated for 10 min at 37~ with: (1) LTA (50/zg/ml) followed 15 min later by washing of the cells 
with HBSS and further treatment for 20 min with anti-LTA Ig (300 #g protein/ml); (2) 20/xl of 
group A streptococci preopsonized with anti-LTA antisera which also contained large amounts of 
agglutinating antibodies to streptococci and with 10% fresh human serum as a source of comple- 
ment; and (3) 20 t~l of  streptococci mixed with 100/~g/ml of histone (type II-A, Sigma). All of 
these agents have been found to induce the generation of large amounts of superoxide, but they did 
not release lactic dehydrogenase (LDH). Cytochalasin B (2.5/~g/ml in DMSO) was added to all 
the tubes. Following incubation, the ceils were removed by centrifugation at 800g for 10 min, and 
the supernatant fluids were assayed with lysosomal enzymes (see below). 
Assay of Lysosomal Enzymes. Paranitrophenyl derivatives of phosphate (50 #g/ml) of N- 
acetylglucosaminide (400/~g/ml),/3-glucuronide (100/zg/ml), and mannose (100/zg/ml) (all Sigma 
products) were added to tubes containing 0.8 ml of 0.1 N acetate buffer, pH 5.0; 150 #1 aliquots 
of  the PMN supernates were added, and the tubes were incubated at 37 ~ for various time intervals 
(see below). The release of free paranitrophenol was determined at 400 nm by the addition of 0.5 
ml of  0.1 N NaOH. Lysozyme was determined by lysis of  M. lysodeikticus. Supernates from PMNs 
which had been frozen and thawed five consecutive times were considered to contain 100% of the 
total amount of enzymes. 
Effect of Drugs on 02 Generation lnduced by LTA-Anti-LTA Complexes. The following 
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drugs were tested for their capacity to modulate the generation of superoxide following stimuiation 
of PMNs by LTA-anti-LTA complexes: nordihydroguaiaretic acid (NDGA) (a putuative lipoxy- 
genase inhibitor), indomethacin and ibupmfen (putative cyclooxygenase inhibitors), phenylbuta- 
zone (an antiinflammatory agent), trifluroperazin (an antagonist of calmodulin), and diazobenzene 
sulfonic acid (DASA) (an inhibitor of surface membrane proteins (53). All drugs were dissolved 
in DMSO at 10 mg/ml and further diluted in HBSS to the appropriate concentration. LTA-sensitized 
PMNs were preincnbated with the various drugs for 10 min at 37~ and then further treated with 
anti-LTA globulin. The amounts of NDGA which inhibited superoxide generation by the PMNs 
were below the amounts which reduce cytochmme c. Controls containing the appropriate amounts 
of DMSO were mn in parallel. None of the drugs, at the concentrations employed, had any cyto- 
toxic effects on the PMNs as determined by the release of lactic dehydrogenase. 
RESULTS 
Generation of Of by LTA-Anti-LTA Complexes. Figure 1 shows that 
PMNs which had been pretreated with increasing concentrations of LTA gen- 
erated progressive amounts of 02- following treatment with anti-LTA globulin. 
This reaction is specific since nonimmune rabbit globulin failed to induce any 
superoxide generation. LTA by itself invariably failed to induce any traces of 
g 
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Fig. 1. Generation of O~- by LTA-sensitized PMNs treated with anti-LTA. PMNs (106/ml) were 
preincubated for 15 min at 37~ with increasing amounts of LTA. The cells were washed, resus- 
pended in HBSS, and exposed to anti-LTA Ig (250 ~g protein/ml) ( r  r  or to nonimmune 
rabbit Ig (250 #g/protein) (9 9 
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O2. Optimal generation of O2 by the LTA-anti-LTA complexes depends on 
the presence of extracellular calcium and magnesium (not shown). Figure 2 
compares the time course of O2 generation induced by LTA-anti-LTA and by 
BSA-anti-BSA complexes. The reaction mixtures were incubated at 25~ to 
allow a slower rate of O2 generation. This also was done to determine the lag 
periods of 02 generation. The onset of 02 generation by the LTA complex 
was much faster and the lag period for O2 generation shorter than that induced 
by the BSA-anti-BSA complex. While 1.5 rain were needed to induce the gen- 
eration of half-maximal amounts of O2 by the LTA-anti-LTA complex, about 
8 min were needed to achieve half-maximal generation of Oy by the BSA-anti- 
BSA complexes. When assayed at 37~ the half-maximal generation of 02 by 
the LTA-anti-LTA and by the BSA-anti-BSA complexes was 1 and 4 min, 
respectively. It was not possible to determine with accuracy the lag period of 
Oy generation induced by LTA-anti-LTA complexes with the method 
employed. 
The rapid onset of O2 generation by the LTA complex might be linked 
with the intense agglutination of the cells which took place following the addi- 
tion of anti-LTA antibodies and the capacity of the same LTA-sensitized PMNs 
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Fig. 2. Time course of 0 2 generation induced by LTA and by BSA complexes. 3 x 106 PMNs 
were treated with LTA (100 /zg/ml) for 15 min at 37~ The cells were washed, and anti-LTA 
globulin (250 /,g protein/ml) was added to each of the tubes containing LTA-sensitized PMNs 
(O O). In parallel, the same number of nonsensitized PMNs were treated with 10 izl of BSA- 
anti BSA complexes (see Materials and Methods) ( H ) .  The reaction mixtures were incubated 
for various time intervals at 25~ in a shaking bath in the presence of CYB (2.5 t~g/ml) and 
cytochrome c (80/zM). 
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to further interact via the Fc portion of the immunoglobulin with neighboring 
PMNs (see below). 
As was the case with superoxide generation, chemiluminescence signals 
were also generated very rapidly (within seconds) following the addition of anti- 
LTA globulin to presensitized PMNs (Figure 3). It was also found that about 
50 % inhibition of superoxide generation induced by BSA-anti-BSA complexes 
took place (Figure 4) when such complexes were added to LTA-presensitized 
PMNs, suggesting that LTA might have somehow blocked Fc receptors on 
PMNs. Even higher inhibitory effects (70%) were noticed when small amounts 
of BSA-anti-BSA complexes were employed to stimulate the LTA-presensi- 
tized PMNs. Despite such inhibition, the total amount of O2 generated when 
PMNs were simultaneously challenged with LTA-anti-LTA and with BSA- 
anti-BSA complexes was always greater than the amounts induced by each com- 
plex alone. These results suggest that "multiple hits" induced by two or more 
ligands might enhance the oxygen burst in leukocytes (see 53, 56). 
The dependence of O2 generation on the amount of anti-LTA globulin and 
the relationship of O~- production to the agglutination of PMNs is shown in 
Figure 5. A marked increase in both superoxide generation and cell agglutina- 
tion occurred proportional to the amount of anti-LTA globulin, suggesting that 
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Fig. 3. Luminol-dependent chemiluminescence (LDCL) induced in PMNs by LTA-anti-Lta com- 
plexes. PMNs (2.5 x 106/ml) were preincubated for 15 min at 37~ with 25/zg/ml of LTA. The 
cells were washed, resuspended in HBSS, and treated (arrow) either with anti-LTA globulin (250 
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Fig. 4. Superoxide generation by ETA-sensitized PMNs challenged by BSA-anti-BSA complexes. 
PMNs (30 x 106/ml were pretreated for 20 min at 37~ with LTA (500/~g/ml). The ceils were 
washed in HBSS, and an aliquot of 3 • 106 cells was treated with increasing amounts of BSA- 
anti-BSA complex (O O) (see Materials and Methods). In parallel 3 x 106 nonsensitized PMNs 
were treated by BSA complexes ( m ) .  Both CYB (2.5 #g/ml) and cytochrome c (80 /zM) 
were added to all tubes, and the reaction mixtures were further incubated for 10 min at 37~ Note 
that LTA-presensitized PMNs produced less superoxide when challenged by the immune complex. 
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Fig. 5. Effect of anti-ETA concentration on Oy generation by PMNs sensitized by ETA. 3 x 106 
PMNs were preincubated for 15 min at 37~ with 50/zg/ml of LTA isolated from Streptococcus 
pyogenes. The cells were washed with saline, resuspended in HBSS, and treated with increasing 
amounts of rabbit-anti LTA IgG ( m )  or with nonimmune rabbit UgG (&). AGGLT = 
degree of PMN agglutination: *, several cells per clump; **, 5-10 cells/clump; ***, 20-50 cells 
per clump; ***% over 50 cells per clump. 
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LTA had been bound to the PMN surfaces prior  to its interaction with ant i -LTA 
antibodies.  Nonspecific rabbit Ig failed to induce either agglutination or super- 
oxide generation. 
The effect of  cytochalasin B (CYB) on Oy  generation by L T A - a n t i - L T A  
complexes is shown in Figure 6. Much larger amounts of  superoxide were gen- 
erated in the presence of  CYB which is similar to the findings with other ligands 
(49). As expected,  L T A - a n t i - L T A  complexes also induced the generation of  
H202 by PMNs.  
Since proteases were found to enhance the binding of  LTA to RBC, pre- 
sumably by unmasking more binding sites (19), we also treated PMNs either 
with crystall ine trypsin (10/xg/ml)  or with pronase (10/xg/ml) and tested their 
capacity to generate O2 following stimulation with L T A - a n t i - L T A  complexes.  
A 20-30  % enhancement of  superoxide generation over  controls was invariably 
observed (data not shown), suggesting that proteases released from activated 
leukocytes in vivo might also enhance oxygen radical generation by PMNs 
stimulated by L T A - a n t i - L T A  complexes.  Since LTA of  all Gram-posi t ive bac- 
teria cross-react  immunological ly  (13) and since normal human serum always 
contains ant i -LTA antibodies,  it is l ikely that sensitization of  mammalian cells 
with LTA is a common occurrence in vivo. Since LTA bound to PMNs interacts 
with ant i -LTA antibodies,  the Fc portion of  the immunoglobulin might also be 
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Fig. 6. Generation of oxygen radicals by PMNs treated with LTA-anti-LTA complexes. PMNs 
(3 x 106/ml) in HBSS + azide (10 mM) were preincubated for 20 rain at 37~ with LTA (50/zg/ 
ml). The cells were then washed in HBSS and resuspended in the same buffer and treated with 
increasing concentrations of anti-LTA-Ig in the absence or presence of CYB (2.5 /zg/ml). 
o o, superoxide; r =, superoxide generation in the presence of CYB; A A, 
hydrogen peroxide. Note that CYB enchanced 02 generation and that the ratio of 02 to H202 
generated by LTA and anti-LTA complexes is about 1.4. 
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free to interact with nonsensitized PMNs. This might further increase the 
amounts of superoxide. 
Effect of Bystander PMNs on O~ Generation Induced by LTA-Anti-LTA 
Complexes. Since PMNs incubated with LTA and then interacted with anti- 
LTA globulin might further interact via the Fc portion of the antibody molecule 
with nonpretreated bystander PMNs, we measured O~- generation in a mixture 
of PMNs, some of which had been incubated with LTA and some of which had 
not been preincubated with LTA. Thirty x 106 PMNs were preincubated for 
20 min at 37~ with 1 mg/ml of LTA. The cells were washed with HBSS to 
remove unbound LTA. Increasing numbers of PMNs (1-5 • 106/ml) pretreated 
with LTA were treated with anti-LTA-globulin (250/~g protein/ml) in the pres- 
ence of CYB and cytochrome c. In parallel, to the same numbers of LTA- 
pretreated PMNs were added untreated PMNs so that each tube contained a 
total of 5 x 106 PMNs (i.e., increasing numbers of sensitized PMNs and 
decreasing numbers of nonsensitized PMNs). Anti-LTA globulin (20/zg pro- 
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Fig. 7. Effect of bystander PMNs on superoxide generation induced by LTA-anti-ETA complexes. 
Increasing numbers of  PMNs sensitized with 100 #g/ml of LTA were treated with anti-LTA glob- 
ulin (250 ~g protein/ml) (e-------~).  To similar increasing numbers of LTA-sensitized PMNs were 
added decreasing numbers of nonsensitized PMNs (O o) so that each tube contained a total 
of  5 • 106 PMNs. CYB and cytochrome c (80 #M) werre added to all mixtures. Note the enhance- 
ment of  O~- generation in the presence of bystander ("nonsensit ized") PMNs and that neither 
PMNs alone ( 5 )  nor LTA-treated PMNs (A)  produced O~-. 
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PMNs nor LTA-pretreated PMNs in which no anti-LTA had been added had 
the capacity to generate 0 2 ,  a marked enhancement of O 2 generation took 
place when nonsensitized PMNs were mixed with sensitized cells, suggesting 
that the bystander PMNs interacted, perhaps via the Fc portion of the mem- 
brane-bound antibodies, to augement superoxide generation (see Discussion). 
Since LTA-anti-LTA complexes activate complement via the classical and 
alternative pathways (26, 77) and also since distinct cytopathic changes were 
induced in LTA-sensitized target cells which had been treated with comple- 
ment-sufficient anti-LTA sera (19, 22, 23), it was also of interest to examine 
the possibility that complement activation might also enhance superoxide gen- 
eration. In preliminary experiments performed in collaboration with Dr. G. Till, 
it was found that the addition of either human or guinea pig serum containing 
10-20 CHso units of complement to LTA-sensitized PMNs in the presence of 
anti-LTA globulin did not result in a significant enhancement of superoxide 
generation. 
Effect of Poly-L-Histidine (PHSTD) on Generation of 02 by PMNs Pre- 
treated with LTA-Anti-LTA Complexes. In all the experiments reported above, 
the amounts of 0 2  generated by PMNs (3-5 x 106/ml) following stimulation 
by LTA-anti-LTA complexes seldom exceeded 25 nmol/10 min. Usually 
smaller amounts were recorded. Since the number of PMNs usually yielded 
much more superoxide following stimulation either by phorbol esters or by 
PHSTD (49, 52), it was of interest to establish the capacity of PMNs which 
had been stimulated by LTA-anti-LTA complexes to produce additional 
amounts of 02 .  This was tested in a system where the PMNs were first stim- 
ulated by LTA-anti-LTA and then further stimulated either with poly-L-histi- 
dine (49) or with PMA. PHSTD had been shown by us to be one of the most 
potent stimulators of superoxide generation known (49, 52). Table 1 shows that 
while approximately 50 nmol of 0 2  are generated by 5 • 106 PMNs stimulated 
by PHSTD, PMNs pretreated with LTA-anti-LTA complexes yielded approx- 
imately 30 nmol of 02 .  Protease pretreatment of PMNs prior to the addition of 
LTA enhanced O2 generation following the addition of anti-LTA. A further 
substantial enhancement of O [  generation occurred, however, when the LTA- 
anti-LTA-treated cells were treated with PHSTD, suggesting that LTA-anti- 
LTA complexes did not exhaust the O2-generating capacity of PMNs and that 
LTA-treated cells might further respond to other ligands with a further gener- 
ation of 02 .  Similar results (data not shown) were obtained with PMA. The 
only case in which PHSTD failed to further augment 0 2  generation was the 
reaction mixture containing anti-LTA Ig (Table 1). Since no such effect was 
obtained with PMA, it was assumed that serum globulin interfered with the 
interaction of PHSTD with the PMNs. This assumption was corroborated 
employing nonspecific rabbit globulin. PHSTD also failed to enhance 0 2  gen- 
eration in the presence of CYB in reaction mixtures containing PMNs which 
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Table 1. Effect of Poly-L-Histidine (PHSTD) on Generation of O~- by PMNs Stimulated by LTA- 
Auti-LTA Complexes a 
O~ generated (nmol) 
- CYB + CYB 
PMNs pretreated with Followed by +PHSTD +PHSTD 
None None 9.6 38.8 7.4 19.4 
LTA Anti-LTA 30.6 39.5 48.6 48.6 
LTA + trypsin Anti-LTA 35.2 42.7 48.3 49. 
LTA + pronase Anti-LTA 39.6 47.2 52.7 53. 
None Anti- LTA 10.1 17.7 8.1 18.0 
LTA None 11.8 42.4 8.8 19.0 
LTA + trypsin None 11.0 39.4 7.0 8.0 
LTA + pronase None 8.0 41.3 8.1 12.0 
Poly-L-histidine (150/~gtml) None 50.6 -- 48.0 -- 
~Neutrophils (5 • 106) were pretreated for 20 min at 37~ either with HBSS, trypsin (10/~g/ml) 
or pronase (10/~g/ml) in the presence of LTA (30/zg/ml), or with PHSTD (150 t~g/ml). The cells 
were washed in HBSS, and anti-LTA Ig (250/zg protein/ml) plus cytochrome c (80 ~M) were 
added in the absence or presence of cytochalasin B (CYB) (2.5 t~g/ml). The reaction mixtures 
were agitated and further incubated for 10 min at 37~ The supernates were read at 550 nm, 
returned to the tubes, which were agitated once more, and PHSTD (150 ~g/ml) was added as a 
stimulus. The tubes were again agitated vigorously and returned to the water bath for 10 additional 
minutes at 37~ The tubes were centrifuged at 2000 rpm and the supernates were again read at 
550 nm. 
had been  pret reated wi th  L T A  and wi th  proteases ,  but  which  were  not  further  
t reated with  a n t i - L T A  Ig. The  reasons  for  this p h e n o m e n o n  are not  unders tood,  
howeve r .  
Effect of Histone on Superoxide Generation. Prev ious  studies f rom our  
labora tory  have  shown that ca t ionic  po lye lec t ro ly tes  marked ly  enhance  super- 
ox ide  genera t ion  by i m m u n e  c o m p l e x e s  (49, 52, 54 -56) .  It was,  therefore ,  o f  
interest  to e x a m i n e  the effect  o f  h is tone  on superoxide  genera t ion  induced by 
L T A - a n t i - L T A  c o m p l e x e s  (data not  shown) .  A 3 0 - 5 4  % enhancemen t  o f  super-  
ox ide  genera t ion  took  p lace  w h e n  increas ing concent ra t ions  o f  h is tone (10-100  
/zg/ml) were  added  to L T A - s e n s i t i z e d  P M N s  in the presence  o f  a n t i - L T A  glob-  
ulin.  On  the o ther  hand no signif icant  genera t ion  o f  O y  was  observed  when  
LTA-sens i t i z ed  P M N s  were  t reated with  h is tone  a lone in the absence  o f  anti- 
L T A .  These  results  sugges t  that ca t ionic  agents  migh t  enhance  the interact ion 
o f  ant ibodies  wi th  ant igens  present  on the surface o f  cei ls  (55, 56). 
Superoxide Generation by PMNs which Interacted with LTA-Anti-LTA- 
Treated Target Cells. Since  L T A  might  also bind to a var ie ty  o f  target  cells  
(1, 6, 14, 17, 19) it was o f  interest  to examine  the possibi l i ty  that such sensi-  
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tized cells might further interact with anti~LTA antibodies and with PMNs to 
generate oxygen radicals. Fibroblasts and epithelial cells were grown in 
monolayers. The cells were trypsinized, washed in HBSS-HEPES,  and resus- 
pended in the same buffer. The cells were then pretreated for 20 min at 37~ 
with LTA and, again, washed in buffer. In some experiments, the cells were 
simultaneously treated with LTA and with proteases and washed. Anti-LTA or 
nonimmune rabbit globulin were then added in the presence of PMNs. Super- 
oxide generation was determined after a further incubation for 20 min at 37~ 
Table 2 shows that larger amounts of superoxide are generated by PMNs which 
had interacted with protease-treated target cells as compared with nontreated 
targets. These data indicate that LTA can be presented to neutrophils by non- 
neutrophilic cells in a manner  that will activate superoxide generation in the 
former and in the presence of anti-LTA. 
Combined Effect of LTA and Membrane-Active Ligands on 02 Genera- 
tion. Previous studies (56) have shown that PMNs which had been primed 
either with the chemotactic peptide formylated methionyl leucine phenylalanine 
(FMLP) or with poly-L-arginine generated large amounts of 02- when chal- 
lenged by lectins. Since lipopolysaccharide (LPS), like LTA, also binds to 
membranes of cells via its lipid moiety, it was of interest to examine the pos- 
Table 2. Generation of Superoxide by PMNs that Interacted with Target Cells Presensitized with 
LTA-Anti-LTA Complexes 
Oy Generation 
(nmol) by PMNs acting on 
Target cells 
treated with" Followed by Fibroblasts Kidney cells 
None Anti-LTA + PMNs 7.0 8.1 
LTA Anti-LTA + PMNs 2t.0 18.0 
LTA PMNs 10.0 10.7 
LTA + trypsin Anti-LTA + PMNs 25.0 24.4 
LTA + pronase Anti-LTA + PMNs 23.3 23.9 
LTA Rabbit Ig + PMNs 6.5 7.0 
None PMNs 6.8 6.8 
"Fibroblasts (4 • 106/ml) or kidney ceils (4 x 106/ml) suspended in HBSS were treated for 15 
rain at 37~ either with buffer and trypsin (10 #g/ml), or with pronase (10 ~g/ml) in the presence 
of LTA (50 ~g/ml). The cells were washed in HBSS, resuspended in HBSS, and either anti-LTA 
globulin (250/zg protein/ml) or nonspecific rabbit globulin (250 tzg protein/ml) was added. PMNs 
(3.75 x 106/ml) were then mixed with the target ceils in the presence of cytochrome c (80/~M) 
and cytochalasin B (2.5 #g/ml). The reaction mixtures were vortexed vigorously and further incu- 
bated for 10 min at 37 ~ Note that PMNs generate 02 following interaction with LTA-sensitized 
targe cells, that protease treatment enhances 02 generation, and that nonspecific rabbit globulin 
fails to trigger radical generation. 
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sible collaboration among LPS, LTA, and other membrane-active ligands in 
02 generation. The ligands chosen to study synergism with LTA were: LPS, 
phytohemagglutinin (PHA), concanavalin A (Con A), the chemotactic peptide 
FMLP, the polyanion polyanethole sulfonate, and the polycations poly-L-argi- 
nine, poly-L-histidine, and histone. Except for polyhistidine all of the ligands 
employed singly induced the generation of relatively small amounts of super- 
oxide (56). PMNs (2 • 106/ml) were preincubated for 15 min at 37~ with 
LTA (20/zg/ml). The various ligands were then added in the presence of cyto- 
chrome c, and the reaction mixtures were further incubated for 10 min at 37~ 
Preincubation of PMNs with LTA depressed O~- generation following the addi- 
tion of polyanethole sulfonate by approximately 35 %. LTA by itself did not 
induce any Oy generation above the levels generated by the PMNs. Similar 
suppression of O~- generation took place when small amounts of polyhistidine 
were employed to stimulate LTA-sensitized PMNs. None of the other ligands 
employed triggered any enhanced generation of superoxide when added to LTA- 
sensitized PMNs. The data suggest that, unlike LPS, LTA could not prime 
PMNs for enhanced generation of O~- after addition of another tigand. 
Release of Lysosomal Enzyme by LTA-Anti-LTA Complexes. Human 
PMNs (5 • 106/ml) in HBSS containing 2.5 #g/ml of cytochalasin B were 
incubated for 30 min at 37~ with: (1) LTA (30 /~g/ml)-anti-LTA (100 /~g 
protein/ml) complexes; (2) group A streptococci preopsonized with rabbit anti- 
streptococcal globulin containing agglutinating antibodies to streptococci and 
supplemented with 10% fresh human serum as a source of complement; (3) 
group A streptococci (108/ml) mixed with histone (100/zg/ml). The reaction 
mixtures were then centrifuged 200g for 10 min, and the supematant fluids were 
assayed for content of acid phosphatase (PHOSPH),/3-glucuronidase (GLUC), 
N-acetylglucosaminidease (NAGA), mannosidase (MANN), and lysozyme 
(LYZ). In parallel, PMNs sensitized with LTA and then treated with anti-LTA 
globulin were also tested for their capacity to generate 0 2. Supematant fluids 
from PMNs subjected to five cycles of freezing and thawing were considered 
to contain the bulk of lysosomal enzymes. Figure 8 shows that LTA-anti-LTA 
complexes triggered the release of lysosomal enzymes. However, the degree of 
release of the five enzymes measured was lower than that induced by the opson- 
ized particles. Since all ligands employed induced the generation of similar 
amounts of superoxide, the stimulation for enzyme release is not necessarily 
parallel to the stimulation needed to activate the NADPH oxidase in the PMN 
membranes. 
Effect of Drugs on O~ Generated by LTA-Anti-LTA Complexes. A vari- 
ety of nonsteroidal and steroidal antiinflammatory drugs strongly inhibit oxygen 
radical generation by PMNs activated by both soluble and particulate ligands 
(59-62). Calmodulin inhibitors (63) and agents which interact with membrane 
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Fig. 8. Release of lysosomal enzymes and generation of superoxide by PMNs treated by various 
agonists. PMNs (5 • 106/ml) were treated for 30 rain at 37~ with LTA-anti-LTA complexes, 
streptococci opsonized with anti-streptococci Ig + 10% fresh human serum as a source of com- 
plement, and streptococci mixed with histone (100/~g/ml). CYB (2.5 g/ml) was added to all reac- 
tion mixtures. The release of acid phosphatase (PHOSPH), /3-glucoronidase 03-GLUC), N- 
acetylglucosaminidase (NAGA), mannosidase (MANN), and lysozyme (LYZ) was determined in 
the supernates. In parallel, 3 • 106 PMNs/ml were stimulated by the same ligands, and the amounts 
of O2 generated after 15 rain of  incubation at 37~ was also determined. The data represent the 
means and standard deviations of five experiments performed with PMNs from five different blood 
donors. 
proteins (53) were also found to be strong inhibitors of oxygen radical genera- 
tion. Since LTA-anti-LTA complexes interact with PMN membranes and since 
the Oz-generating system of PMNs is associated with tee cell surface (64), it 
was of interest to test the effects of a variety of drugs on the generation of 
superoxide by the LTA-anti-LTA system. The various drugs were dissolved in 
DMSO at 10 mg/ml and further diluted in saline to the appropriate concentra- 
tions. PMNs were preincubated for 10 min at 37~ with the drugs, followed 
by the addition of anti-LTA globulin, CYB, and cytochrome c. Figure 9 shows 
that strong inhibition of O~- generation took place with NDGA, phenylbuta- 
zone, TFP, and DASA. On the other hand, even at millimolar concentrations, 
neither indomethacin nor ibuprofen had any significant inhibitory effects on 
superoxide generation by the LTA system. These data are in line with other 
findings which suggest that O~- generation by LTA-anti-LTA complexes 
requires an intact lipoxygenase pathway. 
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Fig. 9. Effect of drugs on O~ generation inducated by LTA-anti-LTA complexes. 5 x 106//~g 
LTA-presensitized PMNs (5 x 106/ml) (see Figure 6) were preincubated for 10 min at 37~ with 
increasing amounts of NDGA ( ~ ) ,  trifluorperazin (o O), phenylbutazone 
(A A), DASA, ( m ) ,  indomethacin ([] []), and ibuprofen ( | 1 7 4  Anti- 
LTA Ig (250/zg protein/ml), CYB (2.5 tzg/ml), and cytochrome c (80/~M) were then added, and 
the reaction mixtures were incubated for 15 rain at 37~ Note the strong inhibition, at micromolar 
concentration, of 02 generation by NDGA, TFP, and phenylbutazone, and the ineffective inhibi- 
tion by millimolar concentrations of indomethacin and ibuprofen. 
D I S C U S S I O N  
Lipoteichoic acid (LTA) is an ampiphatic macromolecular  substance that 
interacts via its lipid moiety with membranes of  mammalian cells (2, 4, 6-9).  
Such "sens i t i zed"  cells undergo agglutination and lysis following the addition 
of  ant i -LTA antibodies and complement  (4, 5, 7 -9 ,  19). Since the putative 
binding sites for LTA in mammal ian  cells might be associated with phospho- 
lipids and cholesterol esters (19), it was expected the LTA might induce a trans- 
membrane  signal in PMNs leading to the activation of  the NADPH oxidase in 
the membrane  and generation of  oxygen radicals. Our findings that no signifi- 
cant generation of such radicals took place when PMNs had been treated with 
large amounts of  LTA alone suggests that not every agent which binds to PMN 
membranes  elicits a respiratory burst. Thus, LTA differs from other membrane-  
perturbing agents, e .g. ,  lectins (65), FMLP peptides (66, 67), saponin (68), 
digitonin (68), lysolecithin (69), cationic poly-amino acids (49, 52, 55, 56), 
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lipopolysaccharides (58), etc., which bind to PMN and macrophage membranes 
and elicit a respiratory burst. To secure the generation of O~- and chemilumi- 
nescence (CL), LTA-sensitized PMNs must be further treated with anti-LTA 
antibodies (Figures 1-7). Such cells agglutinated and rapidly generated super- 
oxide. Significant activity was observed less than 1 rain following the addition 
of antibodies (Figure 2). Very rapid oxygen radical generation was also moni- 
tored by chemiluminescence (Figure 3). 
The mechanism by which LTA-anti-LTA complexes trigger a respiratory 
burst is still not fully understood. This system should, however, be compared 
with classical immune complexes such as BSA-anti-BSA, which have been 
shown to trigger the generation of oxygen radicals by neutrophils (46). Figure 
10A is a schematic representation of the interrelationships that might occur when 
PMNs interact with haptens, like LTA, and with anti-LTA antibodies. It may 
be expected that LTA binds to the PMN membrane, presumably to phospho- 
FaFb c Ig ~ ' 
"Bystander PMN" 
j ~ - -  > CHEMILUMINESCENCE 
! ENZYMES 
9 "Bystander PMN" 
TARGET CELL 
Fig. 10. Schematic representation of (A) the interaction of LTA-sensitized PMNs with anti-LTA 
antibodies and with bystander nonsensitized PMNs and (B) the interaction of LTA-sensitized target 
cells (fibroblasts, endothelial cells) with PMNs. 
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lipids, via its lipid moiety (19). This is followed by the interaction of the Fab 
portion of the immunoglobulin with the LTA core already present on the PMN 
surface. Since the Fc portion of the immunoglobulin is unengaged, it might 
further interact either with the Fc receptors of neighboring LTA-sensitized cells 
or with bystander nonsensitized PMNs. The results of these interactions include 
cell agglutination and membrane perturbation leading to the generation of oxy- 
gen radicals (Figures 1-7) and to the release of lysosomal enzymes (Figure 8). 
On the other hand, much less 02 might be generated when PMNs interact with 
LTA-sensitized target cells, like fibroblasts, which do not possess an NADPH 
oxidase and which therefore cannot mount a respiratory burst (Table 2, Figure 
10B). It also appears that the production of O~- by the LTA-anti-LTA system 
might start much earlier than that induced either by LTA bound to the target 
cells or when PMNs are challenged directly with an immune complex (Figure 
2). 
To further prove that bystander PMNs interact with LTA-sensitized PMNs 
via the Fc fraction of the immunoglobulin, F(ab')2 fragments of the anti-LTA 
antibodies should be prepared. Since, however, the bulk of anti-LTA antibodies 
have been found to be associated with the IgM fraction (20), this task is more 
complicated and further studies along these lines are warranted. 
Since the binding of LTA and PMNs markedly depressed 02 generation 
by other immune complexes (Figure 4), it appears that some of the Fc receptors 
of PMNs might be blocked, nonspecifically, by LTA following its interaction 
with phospholipid components of the membrane. These findings might have 
relevance to the modulation of cell destruction under in vivo conditions (see 
below). 
The findings that much larger amounts of O~- are generated when PMNs 
are simultaneously challenged with LTA and with BSA complexes as com- 
pared with the amounts generated with each complex alone is also of interest. 
It appears that although LTA interfered with the binding of BSA complexes to 
PMNs, the two immune complex systems might still induce an augmented res- 
piratory burst, which under in vivo conditions might mimic an infectious site 
rich in multiple cell-membrane-injuring agents. 
The findings that cationic agents further enhance 02 generation induced 
by LTA-anti-LTA complexes is in line with previous findings (54) on the 
enhancement of the reverse Arthus reaction in the skin of rats injected with 
cationized antibodies and challenged intravenously with radiolabeled antigens. 
It appears that the cationic charge upon antibodies might facilitate their inter- 
actions with the antigens. Furthermore, cationized antibodies or antigens might 
persist in the tissues for longer periods (54, 55). 
The finding that CYB markedly enhanced Oy generation induced by LTA- 
anti-LTA complexes (Figure 6) is in line with assumption that CYB and other 
cytoskeleton-modifying agents might lead to the expansion of the cell mem- 
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brane allowing a better interaction of antibodies with membrane agents like 
LTA. CYB has been shown to augment the generation of 02 and the secretion 
of lysosomal enzymes from neutrophils (49, 52, 56, 71, 72). 
The findings that proteolytic enzymes further enhanced the generation of 
superoxide following stimulation with LTA-anti-LTA complexes is similar to 
our previous observation on the enhancement of binding of LTA to RBC (19). 
The abundance of proteases in inflammatory and infectious sites might therefore 
be responsible for enhancing the generation of toxic oxygen radicals and tissue 
damage. 
The failure to enhance the generation of O2 by adding fresh serum rich in 
complement is in line with the observations (73) that PMNs failed either to 
phagocytize or to generate toxic oxygen radicals when challenged with C3b- 
coated particles. These findings suggest that although the Fc portion of the 
immunoglobulin might be unengaged, complement might not be activated under 
the conditions of our experiments. On the other hand, the findings that LTA- 
anti-LTA complexes not bound to cells readily activate complement (26, 27) 
and that complement activation resulted in the death of a variety of LTA-sen- 
sitized target cells (fibroblasts, tumor cells, and RBCs) (19, 22, 23) indicate 
that further studies to elucidate this controversial finding should be performed. 
Like many other types of immune complexes, LTA-anti-LTA triggers the 
release of lysosomal enzymes from PMNs (Figure 8). However, the finding 
that the levels of the five enzymes measured which had been release by the LTA 
system are much lower than those induced by opsonized particles suggests that 
different agonists vary in their capacity to induce the type of membrane pertur- 
bation leading to degranulation. It is of interest that all three stimulators 
employed in the enzyme release assays triggered the generation of comparable 
amounts of superoxide, suggesting that the signals which elicit a respiratory" 
burst and enzyme release might be different. 
The inhibition of O~- generation indicated by the LTA system by putative 
inhibitors of the lipoxygenase pathway of arachidonic acid metabolism, by cal- 
modulin antagonists, by phenylbutazone, as well as by DASA, an agent shown 
to inhibit surface membrane proteins (Figure 8), suggests that LTA complexes 
might enhance conversion of arachidonic acid to certain intermediates associ- 
ated with the NADPH oxidase. Intracellular calcium is needed for such a reac- 
tion, and inhibition of a still unknown surface protein participates in the complex 
metabolic pathway leading to the generation of oxygen radicals. 
Finally, the possible role played by LTA-anti-LTA complexes in the ini- 
tiation of tissue damage in vivo should be briefly discussed. LTA is synthesized 
by all Gram-positive bacteria. This ampiphatic substance might facilitate the 
adherence of bacterial cells to cell surfaces which then facilitates the invasion 
of bacteria (14-17). Since LTA might be released from bacterial cells either by 
polycationic agents (10) or following bacteriolysis induced by the activation of 
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their own autolytic enzymes (44, 48), it is suggested that free LTA might be 
present in infectious inflammatory sites induced by Gram-positive bacteria, e.g., 
subacute bacterial endocarditis. The facilitation of membrane attachment of LTA 
by proteolytic enzymes might further enhance cytolytic reactions mediated either 
by PMNs (antibody-dependent cellular cytotoxicity) (38) or by complement- 
dependent cellular cytotoxicity (19). Activation of complement by LTA-anti- 
LTA systems might release anaphylatoxin and other mediators of inflammation 
that might augment the inflammatory response. 
The generation of cellular damage (chromium release assays) (38) and of 
oxygen radicals when target cells are treated with LTA-anti-LTA and PMNs 
(Table 2) also suggests that the LTA system might function to further enhance 
cellular cytotoxicity by releasing oxygen radicals and proteases. In preliminary 
experiments (Ginsburg, Varani, and Ward, in press), we found that monolayers 
of fibroblasts, endothelial cells, or fibrosarcoma cells that had been sensitized 
with LTA and treated with anti-LTA globulin and with human neutrophils 
sloughed off the plastic surfaces but were not killed. The incorporation in the 
reaction mixture of sodium azide or aminotriazole (inhibitors of catalase and 
myeloperoxidase) enhanced cell killing, suggesting that these inhibitors pre- 
vented the destruction of hydrogen peroxide produced by the PMNs. Since the 
sloughing off of the monolayers but not killing was totally prevented by pro- 
teinase inhibitors, we assumed that proteolytic enzymes released from the acti- 
vated PMNs were responsible for the disruption of the architecture of the cell 
monolayers. It appears, therefore, that LTA-anti-LTA complexes might prove 
cytolytic and might also facilitate the dislodgement of cells from tissues (74) 
and perhaps also the dissemination of infected cells and tumor cells leading to 
enhanced metastasis. 
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